DK1904056T3 - Anvendelse af et macrolid til at gendanne korneal fölelse - Google Patents
Anvendelse af et macrolid til at gendanne korneal fölelseInfo
- Publication number
- DK1904056T3 DK1904056T3 DK06787603T DK06787603T DK1904056T3 DK 1904056 T3 DK1904056 T3 DK 1904056T3 DK 06787603 T DK06787603 T DK 06787603T DK 06787603 T DK06787603 T DK 06787603T DK 1904056 T3 DK1904056 T3 DK 1904056T3
- Authority
- DK
- Denmark
- Prior art keywords
- macrolide
- corneal sensation
- restore corneal
- administration
- sensation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2093—Leukaemia inhibitory factor [LIF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/183,355 US20070014760A1 (en) | 2005-07-18 | 2005-07-18 | Enhanced recovery following ocular surgery |
US11/263,737 US20070015697A1 (en) | 2005-07-18 | 2005-11-01 | Enhanced ocular neuroprotection and neurostimulation |
PCT/US2006/027713 WO2007011880A2 (en) | 2005-07-18 | 2006-07-18 | Enhanced ocular neuroprotection/neurostimulation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1904056T3 true DK1904056T3 (da) | 2009-08-10 |
Family
ID=37661858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06787603T DK1904056T3 (da) | 2005-07-18 | 2006-07-18 | Anvendelse af et macrolid til at gendanne korneal fölelse |
Country Status (8)
Country | Link |
---|---|
US (4) | US20070014760A1 (da) |
EP (1) | EP2074994A1 (da) |
JP (1) | JP2009501797A (da) |
AT (1) | ATE429914T1 (da) |
BR (1) | BRPI0612859A2 (da) |
DE (1) | DE602006006575D1 (da) |
DK (1) | DK1904056T3 (da) |
ES (1) | ES2326550T3 (da) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004274026A1 (en) * | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
CA2597590A1 (en) | 2005-02-09 | 2006-08-17 | Macusight, Inc. | Formulations for ocular treatment |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
WO2007019427A2 (en) * | 2005-08-08 | 2007-02-15 | Massachusetts Eye & Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
BRPI0707612B8 (pt) | 2006-02-09 | 2021-05-25 | Macusight Inc | vaso lacrado e formulações líquidas contidas no mesmo |
BRPI0709016A2 (pt) | 2006-03-23 | 2011-06-21 | Macusight Inc | formulações e métodos para doenças ou condições relacionadas com a permeabilidade vascular |
US20070237722A1 (en) * | 2006-03-28 | 2007-10-11 | Peyman Gholam A | Neural conduit agent dissemination |
US20070231360A1 (en) * | 2006-03-28 | 2007-10-04 | Minu, L.L.C. | Neural conduit agent dissemination |
US20070237797A1 (en) * | 2006-03-28 | 2007-10-11 | Gholam A. Peyman | Neural Conduit Agent Dissemination |
US20070297991A1 (en) * | 2006-06-23 | 2007-12-27 | Minu, L.L.C. | Neural conduit agent dissemination for smoking cessation and other applications |
US8088789B2 (en) * | 2006-09-13 | 2012-01-03 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
US10695327B2 (en) | 2006-09-13 | 2020-06-30 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
EP2431036B1 (en) * | 2006-09-13 | 2017-04-12 | Elixir Medical Corporation | Macrocyclic lactone compounds and methods for their use |
US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
CN105380947A (zh) * | 2008-03-11 | 2016-03-09 | 万能医药公司 | 大环内酯化合物及它们的使用方法 |
JP2011525890A (ja) * | 2008-03-11 | 2011-09-29 | エリクサー・メディカル・コーポレイション | 大環状ラクトン化合物およびそれらの使用方法 |
CA2720250C (en) | 2008-04-04 | 2018-01-23 | Forsight Labs, Llc | Therapeutic device for pain management and vision |
US20100158821A1 (en) * | 2008-12-22 | 2010-06-24 | Eastman Chemical Company | Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products |
US8106111B2 (en) * | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
US8591025B1 (en) | 2012-09-11 | 2013-11-26 | Nexisvision, Inc. | Eye covering and refractive correction methods for LASIK and other applications |
NO2490635T3 (da) * | 2009-10-23 | 2018-02-03 | ||
EP2490620A4 (en) | 2009-10-23 | 2017-03-22 | Forsight Labs, Llc | Conformable therapeutic shield for vision and pain |
IT1396607B1 (it) * | 2009-11-16 | 2012-12-14 | Hmfra Hungary Ltd Liability Company | Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso. |
CA2816031A1 (en) | 2010-10-25 | 2012-05-10 | Nexisvision, Inc. | Methods and apparatus to identify eye coverings for vision |
US8678584B2 (en) | 2012-04-20 | 2014-03-25 | Nexisvision, Inc. | Contact lenses for refractive correction |
EP2701644B1 (en) | 2011-04-28 | 2018-05-30 | Nexisvision, Inc. | Eye covering having improved tear flow, comfort, and/or applicability |
ITRM20110233A1 (it) * | 2011-05-10 | 2012-11-11 | Univ Calabria | Azitromicina, suoi sali o solvati farmaceuticamente accettabili per l?uso come neuroprotettori. |
US10307292B2 (en) | 2011-07-18 | 2019-06-04 | Mor Research Applications Ltd | Device for adjusting the intraocular pressure |
RU2494707C2 (ru) * | 2011-12-23 | 2013-10-10 | Общество с ограниченной ответственностью "Научно-производственная компания "ФАРМАСОФТ" (ООО "НПК "ФАРМАСОФТ") | Способ лечения открытоугольной глаукомы |
US9465233B2 (en) | 2012-04-20 | 2016-10-11 | Nexisvision, Inc. | Bimodular contact lenses |
WO2013184239A1 (en) | 2012-04-20 | 2013-12-12 | Nexisvision, Inc. | Contact lenses for refractive correction |
EP2877195B1 (en) * | 2012-07-27 | 2018-03-21 | Curonz Holdings Company Limited | Method of treating optic nerve damage, ophthalmic ischemia or ophthalmic reperfusion injury |
CA2916885A1 (en) | 2013-06-26 | 2014-12-31 | Nexisvision, Inc. | Contact lenses for refractive correction |
US9341864B2 (en) | 2013-11-15 | 2016-05-17 | Nexisvision, Inc. | Contact lenses having a reinforcing scaffold |
WO2015116559A1 (en) | 2014-01-29 | 2015-08-06 | Nexisvision, Inc. | Multifocal bimodulus contact lenses |
US20210275020A1 (en) * | 2016-07-18 | 2021-09-09 | Baylor College Of Medicine | Non-contact air esthesiometer |
IT201700066486A1 (it) * | 2017-06-15 | 2018-12-15 | Azienda Ospedaliero Univ Policlinico S Orsola Malpighi Bologn A | Siero sanguigno per uso nel trattamento di patologie neurodegenerative oftalmologiche |
WO2020142349A1 (en) * | 2019-01-04 | 2020-07-09 | The Regents Of The University Of California | Compositions and methods for promoting angiogenesis in the eye |
WO2020228477A1 (zh) * | 2019-05-16 | 2020-11-19 | 沈阳福洋医药科技有限公司 | 一种用于预防、缓解和/或治疗纤维化的药物、组合产品及其应用 |
EP4121062A1 (en) * | 2020-03-19 | 2023-01-25 | Universität Rostock | Josamycin for use in prevention and treatment of fibrosis |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US634693A (en) * | 1899-02-23 | 1899-10-10 | Carnegie Steel Company Ltd | Clamp for poles or columns. |
FR900520A (fr) | 1943-12-13 | 1945-07-02 | Nouveau système de trusquin | |
US4131648A (en) * | 1975-01-28 | 1978-12-26 | Alza Corporation | Structured orthoester and orthocarbonate drug delivery devices |
US4180646A (en) * | 1975-01-28 | 1979-12-25 | Alza Corporation | Novel orthoester polymers and orthocarbonate polymers |
US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4079038A (en) * | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
US4304767A (en) * | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
DE3851152T2 (de) * | 1987-09-03 | 1995-01-26 | Univ Georgia Res Found | Cyclosporin-augenmittel. |
US4946931A (en) * | 1989-06-14 | 1990-08-07 | Pharmaceutical Delivery Systems, Inc. | Polymers containing carboxy-ortho ester and ortho ester linkages |
DK0406791T3 (da) * | 1989-07-05 | 1995-03-27 | Fujisawa Pharmaceutical Co | Vandigt flydende præparat til ekstern anvendelse |
US5294604A (en) * | 1989-12-20 | 1994-03-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating ocular diseases by periocular administration of cyclosporine A or G |
ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
US5788687A (en) * | 1994-02-01 | 1998-08-04 | Caphco, Inc | Compositions and devices for controlled release of active ingredients |
US5457182A (en) * | 1994-02-15 | 1995-10-10 | Merck & Co., Inc. | FK-506 cytosolic binding protein, FKBP12.6 |
US6179817B1 (en) * | 1995-02-22 | 2001-01-30 | Boston Scientific Corporation | Hybrid coating for medical devices |
US6413536B1 (en) * | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
US5968543A (en) * | 1996-01-05 | 1999-10-19 | Advanced Polymer Systems, Inc. | Polymers with controlled physical state and bioerodibility |
WO1997029160A1 (en) * | 1996-02-09 | 1997-08-14 | Surface Solutions Laboratories, Inc. | Water-based hydrophilic coating compositions and articles prepared therefrom |
DE69733338T2 (de) * | 1996-02-13 | 2006-03-16 | G.D. Searle & Co., Chicago | Zubereitungen, enthaltend einen cyclooxygenase-2-inhibitor und einen leukotrien-b4-rezeptor-antagonisten |
US6013763A (en) * | 1996-06-04 | 2000-01-11 | Genentech, Inc. | Peptide variants of protein A |
WO1998010785A1 (fr) * | 1996-09-13 | 1998-03-19 | Advanced Medicine Research Institute | Compositions ophtalmiques de facteurs neurotrophiques, remedes pour troubles fonctionnels du nerf optique et procede de traitement de tels troubles |
US5952371A (en) * | 1996-10-16 | 1999-09-14 | Merck & Co., Inc. | Triterpene derivatives with immunosuppressant activity |
AUPO427196A0 (en) * | 1996-12-19 | 1997-01-23 | University Of Sydney, The | A method for preventing or controlling cataract |
US6670398B2 (en) * | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
US20030181692A1 (en) * | 1997-06-06 | 2003-09-25 | Jian Ni | 207 human secreted proteins |
JPH1180026A (ja) * | 1997-09-02 | 1999-03-23 | Yoshitomi Pharmaceut Ind Ltd | 新規免疫抑制剤、その使用方法およびその同定方法 |
US6015815A (en) * | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
WO1999051215A2 (en) * | 1998-04-06 | 1999-10-14 | Fujisawa Pharmaceutical Co., Ltd. | Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins |
US6218423B1 (en) * | 1998-08-14 | 2001-04-17 | Gpi Nil Holdings, Inc. | Pyrrolidine derivatives for vision and memory disorders |
US6864232B1 (en) * | 1998-12-24 | 2005-03-08 | Sucampo Ag | Agent for treating visual cell function disorder |
US6462071B1 (en) * | 2000-03-02 | 2002-10-08 | Vitreo-Retinal Technologies, Inc. | Agents for intravitreal administration to treat or prevent disorders of the eye |
US6239113B1 (en) * | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
US7063857B1 (en) * | 1999-04-30 | 2006-06-20 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
US6482799B1 (en) * | 1999-05-25 | 2002-11-19 | The Regents Of The University Of California | Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial |
CA2379909C (en) * | 1999-08-06 | 2011-01-04 | Board Of Regents, The University Of Texas System | Drug releasing biodegradable fiber implant |
US6331313B1 (en) * | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US6489335B2 (en) * | 2000-02-18 | 2002-12-03 | Gholam A. Peyman | Treatment of ocular disease |
TR200302105T4 (tr) * | 2000-04-07 | 2004-02-23 | Laboratoire Medidom S. A. | Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları. |
US6613355B2 (en) * | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
US6534693B2 (en) * | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
US6440942B1 (en) * | 2000-12-22 | 2002-08-27 | Enanta Pharmaceuticals, Inc. | 14-membered macrolides derived from leucomycins |
US6462026B1 (en) * | 2001-02-16 | 2002-10-08 | Enanta Pharmaceuticals, Inc. | Bicyclic leucomycins |
US6713081B2 (en) * | 2001-03-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Ocular therapeutic agent delivery devices and methods for making and using such devices |
US6436906B1 (en) * | 2001-04-02 | 2002-08-20 | Enanta Pharmaceuticals, Inc. | 9-amino-14-membered macrolides derived from leucomycins |
US6524606B1 (en) * | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
US20040162315A1 (en) * | 2002-07-23 | 2004-08-19 | Hellberg Mark R. | Use of compounds for treating conditions resulting from injury to the corneal nerve after LASIK and other ocular surgeries or trauma |
US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7087237B2 (en) * | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
US10575605B2 (en) | 2010-03-09 | 2020-03-03 | F.D. Worldwide Merchandise Group, Inc. | Jewelry stones set with prongs and invisible settings |
US10328305B1 (en) | 2016-06-06 | 2019-06-25 | Joseph D Maresh | Exercise machine |
-
2005
- 2005-07-18 US US11/183,355 patent/US20070014760A1/en not_active Abandoned
- 2005-11-01 US US11/263,737 patent/US20070015697A1/en not_active Abandoned
-
2006
- 2006-07-18 ES ES06787603T patent/ES2326550T3/es active Active
- 2006-07-18 DK DK06787603T patent/DK1904056T3/da active
- 2006-07-18 EP EP09004643A patent/EP2074994A1/en not_active Withdrawn
- 2006-07-18 JP JP2008522862A patent/JP2009501797A/ja active Pending
- 2006-07-18 DE DE602006006575T patent/DE602006006575D1/de active Active
- 2006-07-18 AT AT06787603T patent/ATE429914T1/de active
- 2006-07-18 BR BRPI0612859-9A patent/BRPI0612859A2/pt not_active IP Right Cessation
-
2007
- 2007-10-31 US US11/931,938 patent/US20080102101A1/en not_active Abandoned
-
2009
- 2009-01-02 US US12/348,096 patent/US20090143282A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2009501797A (ja) | 2009-01-22 |
BRPI0612859A2 (pt) | 2010-11-30 |
US20090143282A1 (en) | 2009-06-04 |
ATE429914T1 (de) | 2009-05-15 |
DE602006006575D1 (de) | 2009-06-10 |
EP2074994A1 (en) | 2009-07-01 |
US20070014760A1 (en) | 2007-01-18 |
ES2326550T3 (es) | 2009-10-14 |
US20080102101A1 (en) | 2008-05-01 |
US20070015697A1 (en) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1904056T3 (da) | Anvendelse af et macrolid til at gendanne korneal fölelse | |
WO2008140052A1 (ja) | ロピニロール又はその塩を有効成分として含有する後眼部疾患の予防又は治療剤 | |
WO2010068281A3 (en) | Contact lens drug delivery device | |
WO2007011880A3 (en) | Enhanced ocular neuroprotection/neurostimulation | |
TW200505402A (en) | Ophthalmic drug delivery device | |
WO2009137085A3 (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
DK1385452T3 (da) | Anordning til tilförsel af et ophthalmisk medikament | |
ATE535257T1 (de) | Ophthalmologische formulierung mit methylsulfonylmethan und ciprofloxacin | |
WO2007035473A3 (en) | Pharmaceutical delivery device and method for providing ocular treatment | |
EA201300272A1 (ru) | Применение фотоусиливающих агентов в ассоциации с рибофлавином, а также соответствующих офтальмологических композиций для перекрестного сшивания роговицы при лечении кератоконуса или других эктазийных расстройств роговицы | |
CR10041A (es) | Uso de vías inhibitorias coplementarias para el tratamiento de enfermedades oculares | |
JP2009501797A5 (da) | ||
WO2008011836A3 (es) | Soluciones oftálmicas | |
WO2008008330A3 (en) | Deuterated ocular solutions for ltk and other surgical eye procedures | |
WO2013030679A3 (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
BRPI0517891A (pt) | composições compreendendo azelastina e métodos de uso das mesmas | |
MX2009001745A (es) | Tratamiento de enfermedades oculares. | |
ATE459351T1 (de) | Ophthalmologische perkutan absorbierbare zubereitung enthaltend einen muscarin-rezeptor- agonist | |
NO20074850L (no) | Oftalmologiske sammensetninger og anvendelse derav | |
CL2007002386A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento y/o profilaxis de enfermedades seleccionadas de degeneracion macular, neovascularizacion o angiogenesis de la cornea, iris o retina, retinopatia diabetica y no diabetica. | |
MX2008015976A (es) | Tratamiento topico para enfermedades de superficie ocular. | |
EP1870099A4 (en) | PROTECTIVE AGENT FOR RETINAL NEURAL CELL COMPRISING AN INDAZOLE DERIVATIVE AS ACTIVE INGREDIENT | |
BRPI0612005A2 (pt) | agente profilático ou terapêutico, composição oftalmológica, uso de selenoproteína p, e, método de prevenção/tratamento de uma doença corneal/conjuntival | |
UY28202A1 (es) | Utilización de esteroides en el tratamiento de personas que sufren trastonos oculares. | |
NZ602479A (en) | Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion |